Welcome to our dedicated page for Lazard SEC filings (Ticker: LAZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.
Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.
Lazard, Inc. director Ann-Kristin Achleitner received a grant of 3,777 Deferred Stock Units as part of the non-executive director compensation arrangement under the company’s 2018 Incentive Compensation Plan.
These DSUs will convert into an equal number of common shares after she leaves the Board, bringing her total deferred units to 27,036.
Lazard, Inc. director Andrew M. Alper received a grant of 4,068 Deferred Stock Units (DSUs) at a price of $0.00 under the company’s 2018 Incentive Compensation Plan as part of non-executive director compensation. Each DSU will convert into one share of common stock when he leaves the board, bringing his total reported DSU holdings to 103,774.
Lazard, Inc. director Peter Harrison received a grant of 3,777 Deferred Stock Units as part of the company’s Non-Executive Director compensation. Following this award, he holds 8,669 Deferred Stock Units in total. According to the plan, these units convert into common stock on a one-for-one basis when he leaves the board.
Lazard, Inc. director Michelle Jarrard received a grant of 4,010 Deferred Stock Units as part of the company’s non-executive director compensation program. These units carry no cash exercise price and will convert into Common Stock on a one-for-one basis when she leaves the Board. Following this award, she directly holds 47,389 Deferred Stock Units tied to Lazard common shares.
Lazard, Inc. director Iris Knobloch received a grant of Deferred Stock Units as part of her non-executive director compensation. She was awarded 4,010 Deferred Stock Units, bringing her reported holdings of these units to 42,160.
The Deferred Stock Units were granted under Lazard, Inc.'s 2018 Incentive Compensation Plan and will convert into an equal number of shares of common stock on a one-for-one basis after she resigns from, or otherwise ceases to be, a member of the Board of Directors.
SCHULMAN DANIEL H reported acquisition or exercise transactions in this Form 4 filing.
Lazard, Inc. director Daniel H. Schulman received 4,358 Deferred Stock Units (DSUs) as a compensation award. The DSUs were granted under Lazard’s 2018 Incentive Compensation Plan as part of the non-executive director compensation. Following this grant, he holds 15,037 DSUs, each convertible into one share of common stock after he leaves the board.
Lazard, Inc. director Dmitry Shevelenko received 3,777 Deferred Stock Units (DSUs) as a grant under the company’s 2018 Incentive Compensation Plan. These DSUs were awarded as part of the non-executive director compensation arrangement and carry no cash exercise price.
Each DSU will convert into one share of Lazard common stock after Shevelenko resigns from, or otherwise ceases to be, a member of the Board of Directors. Following this award, he now holds a total of 5,903 DSUs, all representing future rights to common shares rather than an immediate stock purchase or sale.
Lazard, Inc. director Stephen R. Howe Jr. received a grant of 4,242 Deferred Stock Units as compensation under the company’s 2018 Incentive Compensation Plan for non-executive directors. Following this award, he holds a total of 14,740 Deferred Stock Units directly.
The Deferred Stock Units are tied to Lazard common stock on a one-for-one basis. They will be converted into shares of common stock after Howe resigns from, or otherwise ceases to be, a member of Lazard’s Board of Directors, making this a deferred, equity-based compensation arrangement rather than an open-market stock transaction.
Lazard, Inc. Chief Financial Officer Tracy Farr received a grant of 393 Restricted Stock Units (RSUs) on Common Stock. These RSUs were acquired under dividend equivalent reinvestment provisions tied to existing RSU awards, so this is a compensation-related award rather than an open-market share purchase.
Following this award, Farr holds 37,969 RSUs, each representing a contingent right to one share of Common Stock. Of the RSUs in this position, 214 are scheduled to vest on or around March 1, 2027, 135 on or around March 1, 2028, and 44 on or around March 1, 2029.
Lazard, Inc. Chief Accounting Officer Michael Gathy received a grant of 134 Restricted Stock Units (RSUs) on May 22, 2026, recorded as a grant/award acquisition. These RSUs were added through dividend equivalent reinvestment on existing RSU awards.
Each RSU represents a contingent right to receive one share of Lazard common stock. Following this grant, Gathy holds 12,892 RSUs, with 62 scheduled to vest on or around March 1, 2027, 53 on or around March 1, 2028, and 19 on or around March 1, 2029. The reported RSU amount excludes 1,438 shares of common stock that he already beneficially owns directly or indirectly.